Public Employees Retirement System of Ohio Has $2.23 Million Stake in Haleon PLC Sponsored ADR $HLN

Public Employees Retirement System of Ohio raised its position in Haleon PLC Sponsored ADR (NYSE:HLN) by 136.4% during the first quarter, Holdings Channel reports. The institutional investor owned 222,708 shares of the company’s stock after buying an additional 128,493 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Haleon were worth $2,229,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of HLN. Brighton Jones LLC bought a new stake in Haleon in the fourth quarter valued at about $187,000. AQR Capital Management LLC increased its holdings in Haleon by 22.5% during the 1st quarter. AQR Capital Management LLC now owns 96,323 shares of the company’s stock worth $991,000 after purchasing an additional 17,720 shares in the last quarter. Focus Partners Wealth raised its position in Haleon by 7.6% in the 1st quarter. Focus Partners Wealth now owns 73,106 shares of the company’s stock valued at $752,000 after buying an additional 5,178 shares during the last quarter. Geneos Wealth Management Inc. lifted its position in shares of Haleon by 33.0% in the first quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock worth $50,000 after purchasing an additional 1,203 shares in the last quarter. Finally, CW Advisors LLC lifted its position in Haleon by 11.6% during the 2nd quarter. CW Advisors LLC now owns 25,075 shares of the company’s stock worth $260,000 after buying an additional 2,601 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Trading Down 2.4%

Shares of HLN stock opened at $9.87 on Friday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.71 and a current ratio of 0.92. Haleon PLC Sponsored ADR has a fifty-two week low of $8.65 and a fifty-two week high of $11.28. The stock has a 50 day simple moving average of $9.44 and a two-hundred day simple moving average of $9.85. The company has a market cap of $43.45 billion, a P/E ratio of 25.29, a PEG ratio of 2.28 and a beta of 0.13.

Haleon Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, September 17th. Stockholders of record on Friday, August 14th will be issued a dividend of $0.0642 per share. The ex-dividend date is Friday, August 14th. This represents a dividend yield of 127.0%. Haleon’s dividend payout ratio is currently 64.10%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on HLN shares. Rothschild & Co Redburn downgraded Haleon from a “strong-buy” rating to a “hold” rating in a report on Tuesday, June 16th. Zacks Research cut shares of Haleon from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 21st. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a report on Tuesday, June 30th. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Haleon in a report on Thursday, April 30th. Finally, Wall Street Zen upgraded shares of Haleon from a “hold” rating to a “buy” rating in a research report on Sunday, July 12th. Two research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy”.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over?the?counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self?care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.